Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

22889fc15db57c89e79827e5ec1b520483ce3118323777ebf589c9803bfb8851

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

SG&A (USD, thousands)

R&D (USD, thousands)

D&A (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

EPS - Basic (USD)

EPS - Diluted (USD)

4ef72864a5a1fffe8e8b2b49295c97f1dc150c68b23d3075b542b8696cc60868

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

f36c464fef1523939bd37eaf691ebcbb682cfdb4a1d41894a3bde841254537f7

Net income (loss) [USD, thousands]

Depreciation of property, plant, and equipment [USD, thousands]

Accretion/Amortization of investments available for sale [USD, thousands]

Change in net pension liability [USD, thousands]

Stock-based compensation expense [USD, thousands]

Provision for sales returns and bad debts/credit losses [USD, thousands]

Inventory provision [USD, thousands]

Net cash provided by (used in) operating activities [USD, thousands]

Acquisition of property and equipment [USD, thousands]

Purchase of investments available for sale [USD, thousands]

Proceeds from sale or maturity of investments available for sale [USD, thousands]

Net cash provided by (used in) investing activities [USD, thousands]

Repayment of finance lease obligations [USD, thousands]

Repurchase of employee common stock for taxes withheld [USD, thousands]

Net cash provided by financing activities [USD, thousands]

Effect of exchange rate changes on cash and cash equivalents [USD, thousands]

Increase (decrease) in cash and cash equivalents [USD, thousands]

Deferred income taxes [USD, thousands]

Cash and cash equivalents, at beginning of year [USD, thousands]

Cash and cash equivalents, at end of the period [USD, thousands]

4db3817a78d4095e68274ef5b115daa2b2aba29cd8b092f21c79e08b84286554

Cash and cash equivalents (USD, thousands)

Investments available for sale - Current (USD, thousands)

Accounts receivable trade, net (USD, thousands)

Inventories, net (USD, thousands)

Prepayments, deposits and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property, plant and equipment, net (USD, thousands)

Finance lease right-of-use assets, net (USD, thousands)

Operating lease right-of-use assets, net (USD, thousands)

Deferred income taxes - Assets (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Obligations under finance leases - Current (USD, thousands)

Obligations under operating leases - Current (USD, thousands)

Allowance for sales returns (USD, thousands)

Other current liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Obligations under operating leases - Non-current (USD, thousands)

Deferred income taxes - Liabilities (USD, thousands)

Asset retirement obligations (USD, thousands)

Pension liability (USD, thousands)

Total liabilities (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

eaaeb39efe61076108c4ba73c51bdd5e19e6bd70bea0788ff25049f7de1468c6

ICLs

- Other Products

-- Cataract IOLs

-- Other Surgical Products

Total Revenue

959bdba8dc2db39ab3e212a3f2608d4e4471e0cdc1d15245ab61865e6b7c70c3

Domestic

Foreign

- China

- Japan

- Other

Americas

EMEA

APAC

- South Korea

968a0b602ab33749f5364e1987d25e32fb8ba5091527c9083864ee145393ab0a

Net sales (USD, thousands)

Cost of sales (USD, thousands)

Gross profit (USD, thousands)

General and administrative expenses (USD, thousands)

Selling and marketing expenses (USD, thousands)

Research and development expenses (USD, thousands)

Total selling, general and administrative expenses (USD, thousands)

Operating income (USD, thousands)

Interest income, net (USD, thousands)

Gain (loss) on foreign currency transactions (USD, thousands)

Royalty income (USD, thousands)

Other income, net (USD, thousands)

Total other income, net (USD, thousands)

Income before income taxes (USD, thousands)

Provision for income taxes (USD, thousands)

Net income (USD, thousands)

Net income per share - Basic (USD)

Net income per share - Diluted (USD)

Weighted average shares outstanding - Basic (thousands)

Weighted average shares outstanding - Diluted (thousands)

3f712ba55825a5c7670f2aa46366c1d0d799150e6dc7ff88d50a0c9e653a7c72

STAAR Surgical Co (STAA)

Financials